Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Pancragen 50–500 mcg MOTS-c 5–15 mg Frequency Multiple times daily Once daily Administration Intramuscular injection Subcutaneous injection Cycle Length 8-12 weeks 4-6 weeks Onset Speed Gradual (3-4 weeks) Moderate (1-2 weeks) Evidence Level Limited

This comparison does not assign a generated winner or score.

  • Dose Range
  • Pancragen
  • 50–500 mcg
  • MOTS-c
  • 5–15 mg
  • Frequency
  • Multiple times daily
  • Once daily
  • Administration
  • Intramuscular injection
  • Subcutaneous injection
  • Cycle Length
  • 8-12 weeks
  • 4-6 weeks
  • Onset Speed
  • Gradual (3-4 weeks)
  • Moderate (1-2 weeks)
  • Evidence Level
  • Limited human trials
  • Strong preclinical (extensive animal studies)
  • Efficacy
More references

Related material

Comparison

MOTS-c vs growth hormone peptides

Growth hormone secretagogues like ipamorelin, CJC-1295, and sermorelin work through growth hormone pathways to affect body composition and metabolism. These peptides stimulate gro…

View details →
Comparison

MOTS-c vs SS-31 (Elamipretide)

Both MOTS-c and SS-31 target mitochondrial function, but through different mechanisms. SS-31 is a synthetic peptide that concentrates in mitochondria and stabilizes cardiolipin, a…

View details →
Comparison

MOTS-c vs AOD-9604

AOD-9604 is a fragment of growth hormone specifically designed to promote fat metabolism without other growth hormone effects. AOD-9604 stimulates lipolysis through growth hormone…

View details →
Comparison

MOTS-c vs metformin

Metformin, a widely-used diabetes medication, also activates AMPK. This has led some to compare MOTS-c to metformin. Both compounds improve insulin sensitivity and have longevity …

View details →